Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate Combination
Clinical trial NCT01321463 · COMPLETED
Trial details
- NCT number
- NCT01321463
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2012-06-01
- Enrollment
- 377
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.